Welcome to Epic Medical Research, where our commitment lies in advancing medical science and enhancing patient care through cutting-edge clinical research. Across our network of 10 sites spanning Arizona, Oklahoma, and Texas, we cater to a diverse patient population of 440,000 individuals. Since 2020, we have conducted over 140 clinical research studies, showcasing our dedication to pushing the boundaries of medical knowledge. Our team of Board-Certified Principal Investigators specializes in a wide array of medical fields, including Internal Medicine, Rheumatology, OBGYN, Pediatrics, Dermatology, Cardiology, Urology, Podiatry, Ophthalmology, General Surgery, Geriatrics, Pain Management, Anesthesiology, Pulmonary Medicine, Critical Care, and Gastroenterology.
Vaccine trials are crucial in advancing public health and preventing the spread of infectious diseases. At Epic Medical Research, we are committed to developing and testing vaccines for various serious illnesses, including COVID-19, influenza, respiratory syncytial virus (RSV), herpes simplex virus (HSV), cytomegalovirus (CMV), norovirus, COVID-19 + influenza combination, and pneumonia. These diseases can lead to severe health complications and significant societal impacts, making vaccine development essential for global health.
Metabolic disorders encompass a range of conditions that affect the body’s ability to properly metabolize nutrients, leading to serious health complications. At Epic Medical Research, we are dedicated to advancing the understanding and treatment of metabolic disorders through clinical trials. We focus on several critical conditions, including type 2 diabetes, type 2 diabetes with obesity, obesity with chronic kidney disease (CKD), hypertension, hyperlipidemia, and non-alcoholic steatohepatitis (NASH). These disorders can significantly impact daily life, increasing the risk of cardiovascular disease, organ damage, and other severe health issues.
Non-Alcoholic Steatohepatitis (NASH) and Metabolic Associated Steatohepatitis (MASH) are severe forms of fatty liver disease, affecting millions of people worldwide. These conditions involve liver inflammation and damage due to fat accumulation, not caused by alcohol consumption. NASH/MASH can lead to serious health complications, including liver fibrosis, cirrhosis, liver failure, and an increased risk of liver cancer.
At Epic Medical Research, we are dedicated to advancing the understanding and treatment of NASH/MASH through clinical trials.
Sleep apnea is a common and potentially serious sleep disorder affecting millions of people worldwide. It is characterized by repeated interruptions in breathing during sleep, leading to poor sleep quality and daytime fatigue. Symptoms include loud snoring, choking or gasping during sleep, morning headaches, and difficulty concentrating. Left untreated, sleep apnea can increase the risk of high blood pressure, heart disease, stroke, and diabetes.
At Epic Medical Research, we are dedicated to advancing the treatment of sleep apnea through clinical trials.
Obesity is a prevalent and serious health condition affecting millions of people worldwide. It is characterized by excessive body fat accumulation, which increases the risk of numerous health issues, including type 2 diabetes, cardiovascular disease, hypertension, certain cancers, and chronic kidney disease (CKD). Obesity can also impact mental health, leading to conditions such as depression and low self-esteem.
At Epic Medical Research, we are committed to advancing the understanding and treatment of obesity through clinical trials.
Asthma is a common chronic respiratory condition affecting millions of Americans, characterized by inflammation and narrowing of the airways, leading to difficulty breathing, wheezing, chest tightness, and coughing. Asthma can significantly impact daily life and overall well-being.
We at Epic Medical Research conduct clinical trials for investigative medications for the treatment of asthma.
Pneumococcal disease is a serious infection caused by the Streptococcus pneumoniae bacteria, affecting millions globally. It can lead to various illnesses, including pneumonia, meningitis, and bloodstream infections, with symptoms such as fever, chills, chest pain, difficulty breathing, and severe headaches. This disease can have a significant impact on health, particularly among young children, the elderly, and individuals with weakened immune systems.
At Epic Medical Research, we are committed to advancing the prevention and treatment of pneumococcal disease through clinical trials.
Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects millions of people worldwide. It occurs when stomach acid frequently flows back into the esophagus, leading to symptoms such as heartburn, regurgitation, chest pain, and difficulty swallowing. GERD can significantly impact daily life, causing discomfort and potential complications such as esophagitis and Barrett's esophagus if left untreated.
At Epic Medical Research, we are committed to advancing the understanding and treatment of GERD through clinical trials.
Diabetic neuropathy is a common and serious complication of diabetes, affecting millions of people worldwide. It is a type of nerve damage caused by prolonged high blood sugar levels, leading to symptoms such as pain, tingling, numbness, and weakness, particularly in the hands and feet. This condition can significantly impair quality of life and daily functioning.
At Epic Medical Research, we are dedicated to advancing the understanding and treatment of diabetic neuropathy through clinical trials.
Low testosterone, or hypogonadism, is a condition affecting millions of men worldwide. It occurs when the body produces insufficient levels of testosterone, a hormone essential for male development and overall health. Symptoms of low testosterone include fatigue, decreased libido, erectile dysfunction, mood swings, reduced muscle mass, and difficulty concentrating. This condition can significantly impact daily life, affecting both physical and mental well-being.
At Epic Medical Research, we are dedicated to advancing the treatment of low testosterone through clinical trials.
Knee osteoarthritis is a common and debilitating joint condition affecting millions of people worldwide. It is characterized by the gradual breakdown of cartilage in the knee joint, leading to pain, stiffness, swelling, and decreased mobility. As the protective cartilage wears away, bones can rub against each other, causing significant discomfort and further joint damage.
At Epic Medical Research, we are dedicated to advancing the treatment of knee osteoarthritis through clinical trials.
Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is characterized by memory loss, cognitive decline, and behavioral changes, severely impacting daily life and overall well-being. As the most common cause of dementia, Alzheimer’s disease gradually destroys brain cells, leading to difficulties in thinking, reasoning, and performing everyday tasks.
At Epic Medical Research, we are dedicated to advancing the understanding and treatment of Alzheimer’s disease through clinical trials.
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, encompassing conditions such as heart disease, stroke, and hypertension. Preventing cardiovascular disease is crucial to improving overall health and longevity. Cardiovascular prevention involves a combination of lifestyle changes, medical interventions, and regular monitoring to reduce the risk of developing heart-related conditions.
At Epic Medical Research, we are dedicated to advancing the understanding and implementation of effective cardiovascular prevention strategies through clinical trials.